- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05841264
Growth Chart Parameters, Risk Factors
April 22, 2023 updated by: Mariana Noss Abdo Abdelmalak, Assiut University
Comparison Between Children Growth Chart Parameters and Their Abnormality Associated Risk Factors in Assiut Governorate
comparison between growth chart parameters and different risk factors which can cause abnormal growth chart parameter
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Infant growth is defined as a positive change in body size over a period of time, and it is a sensitive predictor of an individuals' health.
An inappropriate growth pattern indicates nutritional disorders, chronic and infectious diseases in infants.
Early growth rate is related to adulthood health, such that it is important to develop the concept of appropriate growth for parents, in other to detect children with abnormal growth rates, as soon as possible .Weight and height of preschool children are the most common anthropometric measurements, to investigate a child's growth rate.
Weight is the simplest and most reliable anthropometric measurement, and may be used as an indicator of childhood infection.
On the other hand, height summarizes various measures of nutritional conditions in the first two decades of a human's life.
Many children younger than 5 years in developing countries are exposed to multiple risks, including poverty, malnutrition, poor health, and unstimulating home environments, which detrimentally affect their cognitive, motor, and social-emotional development.
Study Type
Observational
Enrollment (Anticipated)
600
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
children living in different areas have low incomes, high fertility, and provide poor care form their parents different socioeconomic state, different type of food
Description
Inclusion Criteria:
- All children attending primary health care units in Assiut governorate aged from one year to five year
Exclusion Criteria:
- 1. congenital anomalies 2. chronic diseases (D.M , thyroid dysfunction)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
children's in urban area
children's in this have good socioeconomic state, small family number, good hygiene
|
taking healthy food which contain minerals, vitamins essential for normal growth
|
children in rural area
children's in this have bad socioeconomic state, large family number, bad hygiene
|
taking healthy food which contain minerals, vitamins essential for normal growth
|
children in semi urban area
children's in this have bad socioeconomic state, small family number, bad hygiene
|
taking healthy food which contain minerals, vitamins essential for normal growth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
comparison of growth and development of children in different areas in Assiut governorate
Time Frame: through study completion, an average of 1 year
|
by using WHO growth chart for weight and height parameter, if child weight and height in normal average or not
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
factors affecting growth and development of children in different areas in Assiut governorate
Time Frame: through study completion, an average of 1 year
|
questionnaire about different factors that can affect child growth
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2023
Primary Completion (Anticipated)
December 1, 2024
Study Completion (Anticipated)
June 1, 2025
Study Registration Dates
First Submitted
April 10, 2023
First Submitted That Met QC Criteria
April 22, 2023
First Posted (Actual)
May 3, 2023
Study Record Updates
Last Update Posted (Actual)
May 3, 2023
Last Update Submitted That Met QC Criteria
April 22, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Growth chart, Risk factors
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth Disorders
-
Northwell HealthRecruitingGrowth | Growth Disorders | Growth Failure | Growth Hormone TreatmentUnited States
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
IpsenCompletedGrowth Hormone DisordersUnited Kingdom
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Cornell UniversityAfrica Future FoundationCompletedMalnutrition | Growth | Stunted Growth | Feeding, ComplementaryEthiopia
-
Novo Nordisk A/SWithdrawnHealthy | Growth Disorder
-
Novo Nordisk A/SCompletedHealthy | Growth DisorderUnited States
-
Indonesia UniversityWyeth nutrition indonesiaCompletedGrowth; Stunting, NutritionalIndonesia
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
Clinical Trials on good feeding, cleaning
-
Faculty Sao Leopoldo Mandic CampinasUnknown
-
Equiti Food, LLCNational Institutes of Health (NIH); University of North Carolina, Chapel Hill and other collaboratorsEnrolling by invitation
-
University of Massachusetts, WorcesterCompletedObesity | OverweightUnited States
-
London School of Hygiene and Tropical MedicineMakerere University; Raising Voices; Institute of Education, UKCompletedMental Health | Sexual Violence | Physical Violence | Educational Achievement | Violence Against ChildrenUganda
-
Malmö UniversityLund UniversityCompletedPulmonary Disease, Chronic Obstructive | Dental Plaque | COPD ExacerbationSweden
-
University of Maryland, BaltimoreCompletedInfection ControlUnited States
-
Massachusetts General HospitalWest Virginia University; endOclear, LLC.CompletedAirway Obstruction | Pneumonia, Ventilator-Associated | Endotracheal Extubation | Airway Control | Breathing MechanicsUnited States
-
Parc de Salut MarHospital del Mar Research Institute (IMIM); COIB, Col·legi d'Infermers i infermeres... and other collaboratorsCompletedNurse Physician Relations | Professional Stress | Practice Nurse's Scope | Nurses' Work Environment | Committed Centers With Excellence in Care (CCEC®) Program | Nurses' Evidence-based-practice AttitudesSpain
-
University of LisbonNot yet recruiting
-
Medtronic - MITGTerminated